10th September 2018
- 0 comments
NVM has invested £2.75 million of growth capital (with the balance of the £3.2m funding round provided by existing investors and private individuals) into Reading-based pharmaceutical company Ridge Pharma Limited (“Ridge”). Ridge is an emerging UK pharmaceutical business set to commercialise their first product in late 2018, with further launches thereafter. Ridge was founded on the belief that consistently offering medicines with distinct benefits and clear value is at the heart of a rewarding and sustainable business.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.